BlackRock’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-3,082,031
Closed -$7.03M 5274
2024
Q2
$7.03M Buy
3,082,031
+2,410,004
+359% +$5.49M ﹤0.01% 3513
2024
Q1
$2.9M Sell
672,027
-8,637
-1% -$37.3K ﹤0.01% 3812
2023
Q4
$2.08M Sell
680,664
-439,643
-39% -$1.34M ﹤0.01% 3954
2023
Q3
$1.61M Sell
1,120,307
-65,338
-6% -$94.1K ﹤0.01% 4017
2023
Q2
$2.95M Sell
1,185,645
-201,253
-15% -$501K ﹤0.01% 3815
2023
Q1
$3.72M Sell
1,386,898
-105,611
-7% -$283K ﹤0.01% 3687
2022
Q4
$8.1M Sell
1,492,509
-27,148
-2% -$147K ﹤0.01% 3426
2022
Q3
$19M Buy
1,519,657
+150,376
+11% +$1.88M ﹤0.01% 3012
2022
Q2
$6.76M Sell
1,369,281
-1,930,568
-59% -$9.54M ﹤0.01% 3615
2022
Q1
$25.1M Sell
3,299,849
-10,363
-0.3% -$78.8K ﹤0.01% 2964
2021
Q4
$33.8M Buy
3,310,212
+68,127
+2% +$696K ﹤0.01% 2892
2021
Q3
$43.5M Buy
3,242,085
+12,319
+0.4% +$165K ﹤0.01% 2729
2021
Q2
$70.9M Buy
3,229,766
+80,859
+3% +$1.77M ﹤0.01% 2439
2021
Q1
$75.8M Buy
3,148,907
+255,314
+9% +$6.14M ﹤0.01% 2329
2020
Q4
$52.1M Buy
2,893,593
+262,986
+10% +$4.73M ﹤0.01% 2400
2020
Q3
$30.4M Sell
2,630,607
-53,316
-2% -$616K ﹤0.01% 2551
2020
Q2
$65.1M Buy
2,683,923
+104,756
+4% +$2.54M ﹤0.01% 2086
2020
Q1
$28.4M Sell
2,579,167
-1,192
-0% -$13.1K ﹤0.01% 2387
2019
Q4
$68.2M Sell
2,580,359
-4,556
-0.2% -$120K ﹤0.01% 2162
2019
Q3
$58.9M Buy
2,584,915
+116,500
+5% +$2.65M ﹤0.01% 2181
2019
Q2
$75.7M Buy
2,468,415
+530,999
+27% +$16.3M ﹤0.01% 2074
2019
Q1
$32.2M Sell
1,937,416
-26,298
-1% -$437K ﹤0.01% 2516
2018
Q4
$37.6M Buy
1,963,714
+126,892
+7% +$2.43M ﹤0.01% 2389
2018
Q3
$96M Buy
1,836,822
+146,462
+9% +$7.66M ﹤0.01% 1990
2018
Q2
$73.5M Buy
1,690,360
+409,300
+32% +$17.8M ﹤0.01% 2119
2018
Q1
$47.5M Buy
1,281,060
+535,615
+72% +$19.8M ﹤0.01% 2289
2017
Q4
$14.8M Buy
745,445
+396,215
+113% +$7.86M ﹤0.01% 2911
2017
Q3
$8.69M Buy
349,230
+338,519
+3,160% +$8.43M ﹤0.01% 3198
2017
Q2
$187K Buy
+10,711
New +$187K ﹤0.01% 4199